• TIVANTINIB chembl:CHEMBL2103882 Antineoplastic

    Alternate Names:

    TIVANTINIB
    ARQ-197

    Drug Info:

    Pharmaceutical Developer ArQule and Daiichi Sankyo
    Source Reported Drug Name(s) ARQ 197/Tivantinib
    Drug Class MET Inhibitor
    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    Drug Class Kinase Inhibitors
    (4 More Sources)

    Publications:

    • Version: 25-July-2013

    Alternate Names:
    11494412 PubChem Drug ID
    ARQ 197 Drug Development Name
    ARQ 197 PubChem Drug Name

    Drug Info:
    Drug Class MET Inhibitor
    Source Reported Drug Name(s) ARQ 197/Tivantinib
    Pharmaceutical Developer ArQule and Daiichi Sankyo

    Publications:

    • Version: 20-Jun-2017

    Alternate Names:
    ARQ197 Development Name
    TIVANTINIB Generic Name

    Drug Info:
    Drug Class Kinase Inhibitors

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

    • Version: 29-September-2020

    Alternate Names:
    TIVANTINIB GuideToPharmacology Ligand Name

    Drug Info:

    Publications:

    • Version: 12-May-2016

    Alternate Names:
    ARQ197 Drug Synonym
    TIVANTINIB Drug Generic Name
    TIVANTINIB Primary Drug Name

    Drug Info:

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0ZI1F TTD Drug ID

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: